Basic Information
AviadoBio's mission is to transform the lives of patients with neurodegenerative diseases by developing and delivering transformative gene therapies for conditions such as frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The company's technology is based on groundbreaking research from King's College London and the UK Dementia Research Institute.
AviadoBio Ltd
London,England,United Kingdom
15~50 people
January 01, 2019
--
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios